Crinetics Pharmaceuticals, Inc. - COM (CRNX)

Historical Portfolio Holders from Q3 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
79.7 M
Holdings value Q1 2024
$3.73 B
Value change Q1 2024
+$489 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
193
Number of buys Q1 2024
122
Number of sells Q1 2024
-78
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.002%
CUSIP
22663K107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 79.7 M $3.73 B +$489 M $46.81 196
2023 Q4 69.8 M $2.48 B +$64.1 M $35.58 178
2023 Q3 67.4 M $2 B +$443 M $29.74 169
2023 Q2 53.8 M $969 M -$14.3 M $18.02 134
2023 Q1 55 M $883 M +$109 K $16.06 125
2022 Q4 54.1 M $990 M -$29.2 M $18.30 116
2022 Q3 51.2 M $1.01 B +$12.5 M $19.64 110
2022 Q2 50.5 M $941 M +$94 M $18.65 106
2022 Q1 45.5 M $997 M +$24.8 M $21.95 109
2021 Q4 44.2 M $1.26 B +$251 M $28.41 111
2021 Q3 33.6 M $708 M +$17.1 M $21.05 90
2021 Q2 32.7 M $617 M +$43.3 M $18.85 80
2021 Q1 30.7 M $464 M +$5.7 M $15.28 76
2020 Q4 30.4 M $429 M -$4.59 M $14.11 83
2020 Q3 30.3 M $475 M -$19.9 M $15.67 68
2020 Q2 31.4 M $546 M +$189 M $17.52 77
2020 Q1 20.7 M $304 M +$45.4 M $14.70 53
2019 Q4 17.5 M $440 M -$5.48 M $25.09 56
2019 Q3 15.2 M $229 M -$94.2 M $15.04 59
2019 Q2 15.3 M $383 M +$30.9 M $25.00 60
2019 Q1 17.7 M $403 M +$21 M $22.76 60
2018 Q4 16.8 M $503 M +$19.1 M $29.99 48
2018 Q3 16.2 M $463 M +$463 M $28.65 48